2022
Oral Cyanobacteria and Hepatocellular Carcinoma
Hernandez BY, Zhu X, Risch HA, Lu L, Ma X, Irwin ML, Lim JK, Taddei TH, Pawlish KS, Stroup AM, Brown R, Wang Z, Wong LL, Yu H. Oral Cyanobacteria and Hepatocellular Carcinoma. Cancer Epidemiology Biomarkers & Prevention 2022, 31: 221-229. PMID: 34697061, PMCID: PMC8755591, DOI: 10.1158/1055-9965.epi-21-0804.Peer-Reviewed Original ResearchConceptsHepatitis B virusHepatitis C virusHepatocellular carcinomaRisk factorsLiver diseaseHCC casesOral microbiomeU.S. case-control studyIndependent risk factorChronic liver diseaseFatty liver diseaseHCC risk factorsGut microbial alterationsType 2 diabetesCase-control studyLiver cancer developmentNSAID useAspirin useC virusB virusHCC riskNegative historyOral samplesSignificant associationCancer development
2020
Energetics
Ferrucci L, Irwin M. Energetics. 2020, 303-320. DOI: 10.1007/978-3-030-42011-6_15.Peer-Reviewed Original ResearchWeight loss interventionCancer riskLoss interventionCancer outcomesRisk factorsReduced cancer riskIndependent risk factorEnergy balance interventionsDifferent cancer sitesDiet interventionPhysical inactivityDifferent cancer typesSurrogate markerCancer sitesBalance interventionsPhysical activityNew therapiesPoor dietObesityVaried age groupsAge groupsCancer typesCancer developmentMortalityWeight loss